Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-04 Sale |
2025-02-06 8:27 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
3,770 | $21.38 | $80,615 | 57,235 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 8:27 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
3,921 | $21.38 | $83,836 | 51,704 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 8:27 pm |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
9,352 | $21.39 | $200,075 | 239,454 (Direct) |
View |
| 2025-02-04 Sale |
2025-02-06 8:26 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec |
2,787 | $21.4 | $59,653 | 38,830 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-06 8:18 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
14,519 | $1.1361 | $16,496 | 349,093 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-06 8:18 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
12,628 | $1.1354 | $14,338 | 402,891 (Direct) |
View |
| 2024-02-02 Sale |
2024-02-06 8:18 pm |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
52,894 | $1.1359 | $60,082 | 2,036,629 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
13,475 | $0 | 13,475 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
14,725 | $0 | 14,725 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2034-03-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer |
9,375 | $0 | 9,375 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-19 8:56 pm |
N/A 2031-01-27 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
56,250 | $0 | 56,250 (Direct) |
View |
| 2025-03-17 Option Award |
2025-03-19 8:55 pm |
N/A 2032-12-08 |
RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec |
17,225 | $0 | 17,225 (Direct) |
View |
| 2025-03-06 Option Award |
2025-03-10 5:42 pm |
N/A 2035-03-06 |
RIGEL PHARMACEUTICALS INC | RIGL | Frohlich Mark W Director |
12,000 | $0 | 12,000 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer |
34,505 | $0 | 34,505 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
105,700 | $0 | 312,206 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
34,505 | $0 | 75,793 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:47 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
34,505 | $0 | 70,413 (Direct) |
View |
| 2025-01-29 Option Award |
2025-01-31 6:45 pm |
N/A 2035-01-29 |
RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec |
34,505 | $0 | 56,405 (Direct) |
View |
| 2025-01-24 Tax Withholding |
2025-01-28 8:49 pm |
N/A N/A |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
44,078 | $22.17 | 206,506 (Direct) |
View |
| 2025-01-24 Exercise |
2025-01-28 8:49 pm |
N/A N/A |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
45,000 | $21.4 | 206,506 (Direct) |
View |
| 2025-01-24 Exercise |
2025-01-28 8:49 pm |
N/A 2025-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
90,000 | $0 | 206,506 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-26 8:01 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
8,000 | $0 | 8,000 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-26 8:01 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
30,000 | $0 | 30,000 (Direct) |
View |
| 2024-11-25 Option Award |
2024-11-26 8:01 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
6,250 | $0 | 6,250 (Direct) |
View |
| 2024-08-30 Option Award |
2024-09-04 8:36 pm |
N/A 2030-02-06 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
32,500 | $0 | 32,500 (Direct) |
View |
| 2024-08-30 Option Award |
2024-09-04 8:33 pm |
N/A 2030-02-06 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
10,000 | $0 | 10,000 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:21 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director |
55,000 | $0 | 130,000 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:21 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director |
55,000 | $0 | 132,222 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:20 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 130,000 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:20 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | Kotzin Brian L. Director |
55,000 | $0 | 130,000 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:20 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director |
55,000 | $0 | 111,250 (Direct) |
View |
| 2024-05-25 Option Award |
2024-05-29 7:19 pm |
N/A 2034-05-25 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
55,000 | $0 | 98,750 (Direct) |
View |
| 2024-03-27 Option Award |
2024-03-29 4:09 pm |
N/A 2034-03-27 |
RIGEL PHARMACEUTICALS INC | RIGL | Rojkjaer Lisa EVP, Chief Medical Officer |
187,500 | $0 | 187,500 (Direct) |
View |
| 2024-02-28 Option Award |
2024-03-01 7:16 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
141,000 | $0 | 141,000 (Direct) |
View |
| 2024-02-28 Option Award |
2024-03-01 7:15 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
158,500 | $0 | 158,500 (Direct) |
View |
| 2024-02-28 Option Award |
2024-03-01 7:15 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
600,000 | $0 | 600,000 (Direct) |
View |
| 2024-02-28 Option Award |
2024-03-01 7:14 pm |
N/A 2032-12-08 |
RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec |
172,250 | $0 | 172,250 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 9:17 pm |
N/A 2034-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC, CCO & Corp Sec |
366,000 | $0 | 371,000 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 9:17 pm |
N/A 2034-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
1,000,000 | $0 | 2,689,523 (Direct) |
View |
| 2024-01-23 Option Award |
2024-01-25 9:17 pm |
N/A 2034-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
366,000 | $0 | 520,612 (Direct) |
View |